Status:

UNKNOWN

Human Physiology and Self-Reported Pain Score

Lead Sponsor:

Taichung Veterans General Hospital

Collaborating Sponsors:

Taiwan Mundipharma Pharmaceuticals Ltd.

Conditions:

Cancer Pain

Eligibility:

All Genders

21-70 years

Brief Summary

To assess whether the patient's self-reported pain level is associated with a multivariate physiological biomarker bias achieved in the actual clinical setting. This study will use a clinical-grade we...

Detailed Description

Subjective scores have traditionally been used to measure human pain, such as the visual analog scale (VAS) to determine the presence or absence of pain and its severity. People can only express the p...

Eligibility Criteria

Inclusion

  • There are moderate to severe cancer pain (digital rating scale NRS ≥ 4).
  • Inclusion conditions:
  • Male and female between the ages of 21 and 70
  • Cancer patients diagnosed with moderate to severe cancer pain (digital rating scale NRS ≥ 4)
  • Ability to provide informed consent
  • Be able to commit to using the app during the study and input data as needed
  • The subject must have a smart phone such as an iPhone/iPad (at least iPhone 5S)

Exclusion

  • Previously had myocardial infarction (MI)
  • Coronary artery disease is known - previous coronary angioplasty
  • A previous stroke occurred, and stroke was defined as a new localized nerve defect lasting more than 24 hours.
  • Currently using more than 2 kinds of blood pressure lowering drugs
  • Expected life is less than 1 year
  • Suffering from asthma or chronic lung disease requires long-term medication or oxygen therapy
  • suffering from mental illness, the clinical judgment of the host will affect the participation of the trial, such as dementia
  • Unable to comply with the test plan
  • Any other acute or chronic medical/physiological condition identified by the moderator as affecting the test results

Key Trial Info

Start Date :

August 8 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 14 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04053608

Start Date

August 8 2019

End Date

March 14 2020

Last Update

August 14 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Taichung Veterans General Hospital

Taichung, Taiwan, 407